Skip to main content
Midas Edge

ELI LILLY & Co

For the period ended Sep 30, 2025. Filed Oct 30, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Oct 30, 2025

LLY$1,432.29+1.4%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Consolidated Condensed Statements of Shareholders' Equity

Equity of Eli Lilly and Company Shareholders
(Dollars in millions, except per-share data, and shares in thousands) · Common Stock · AdditionalPaid-inCapital · RetainedEarnings · Employee Benefit Trust · Accumulated Other Comprehensive Loss · Common Stock in Treasury(1) · Noncontrolling Interests
Shares · Amount · Shares · Amount
Balance at July 1, 2024950,781$594.2$7,214.2$13,178.0$(3,013.2)$(4,378.5)365$(32.7)$73.5
Net income970.311.8
Other comprehensive income, net of tax103.7
Retirement of treasury shares(582)(0.3)(520.8)(582)521.1
Purchase of treasury shares582(521.1)
Issuance of stock under employee stock plans, net16—(7.8)
Stock-based compensation133.2
Other(0.3)(4.6)
Balance at September 30, 2024950,215$593.9$7,339.6$13,627.2$(3,013.2)$(4,274.8)365$(32.7)$80.7
Balance at July 1, 2025947,198$592.0$7,089.3$17,376.2$(3,013.2)$(3,716.0)365$(55.4)$76.2
Net income5,582.53.0
Other comprehensive income, net of tax509.7
Retirement of treasury shares(1,011)(0.6)(707.5)(1,011)708.1
Purchase of treasury shares1,011(708.1)
Issuance of stock under employee stock plans, net19—(8.5)
Stock-based compensation151.1
Other0.8(7.1)(21.7)
Balance at September 30, 2025946,206$591.4$7,231.9$22,252.0$(3,013.2)$(3,206.3)365$(62.5)$57.5

(1) As of September 30, 2025, there was $12.40 billion remaining under our $15.00 billion share repurchase program authorized in December 2024.

Equity of Eli Lilly and Company Shareholders
(Dollars in millions, except per-share data, and shares in thousands) · Common Stock · AdditionalPaid-inCapital · RetainedEarnings · Employee Benefit Trust · Accumulated Other Comprehensive Loss · Common Stock in Treasury(1) · Noncontrolling Interests
Shares · Amount · Shares · Amount
Balance at January 1, 2024949,781$593.6$7,250.4$10,312.3$(3,013.2)$(4,327.0)402$(44.2)$91.8
Net income (loss)6,180.2(3.2)
Other comprehensive income, net of tax52.2
Cash dividends declared per share: $2.60(2,342.9)
Retirement of treasury shares(582)(0.3)(520.8)(582)521.1
Purchase of treasury shares582(521.1)
Issuance of stock under employee stock plans, net1,0160.6(414.5)(37)11.5
Stock-based compensation503.7
Other(1.6)(7.9)
Balance at September 30, 2024950,215$593.9$7,339.6$13,627.2$(3,013.2)$(4,274.8)365$(32.7)$80.7
Balance at January 1, 2025947,903$592.4$7,439.3$13,545.0$(3,013.2)$(4,321.9)365$(49.5)$79.5
Net income14,002.328.7
Other comprehensive income, net of tax1,115.6
Cash dividends declared per share: $3.00(2,692.2)
Retirement of treasury shares(3,279)(2.0)(2,598.3)(3,279)2,600.3
Purchase of treasury shares3,279(2,600.3)
Issuance of stock under employee stock plans, net1,5821.0(697.3)
Stock-based compensation489.9
Other(4.8)(13.0)(50.7)
Balance at September 30, 2025946,206$591.4$7,231.9$22,252.0$(3,013.2)$(3,206.3)365$(62.5)$57.5

(1) As of September 30, 2025, there was $12.40 billion remaining under our $15.00 billion share repurchase program authorized in December 2024.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.